Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Medical Officer

Tenax Therapeutics, Inc. develops and commercializes pharmaceutical products containing imatinib for the treatment of pulmonary arterial hypertension. It develops TNX-101 (IV), TNX-102, and TNX-103 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension associated with heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is based in Chapel Hill, North Carolina.

Tenax Therapeutics, Inc. develops and commercializes pharmaceutical products containing imatinib for the treatment of pulmonary arterial h...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2022-09-21	Premium	gifted	Premium	Premium	Premium	Chief Medical Officer
2022-09-21	Premium	gifted	Premium	Premium	Premium	Chief Medical Officer
2022-08-11	Premium	gifted	Premium	Premium	Premium	-
2022-08-11	Premium	gifted	Premium	Premium	Premium	-
2021-11-29	Premium	gifted	Premium	Premium	Premium	Chief Medical Officer
2021-11-29	Premium	gifted	Premium	Premium	Premium	Chief Medical Officer
2021-10-12	Premium	gifted	Premium	Premium	Premium	Chief Medical Officer
2021-10-12	Premium	gifted	Premium	Premium	Premium	Chief Medical Officer
2021-06-30	Premium	gifted	Premium	Premium	Premium	-
2021-06-11	Premium	acquired	Premium	Premium	Premium	-
2021-06-11	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2021-06-11	Premium	acquired	Premium	Premium	Premium	-
2021-01-15	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2021-01-15	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2020-09-08	Premium	bought	Premium	Premium	Premium	-
2020-09-08	Premium	bought	Premium	Premium	Premium	-
2020-09-04	Premium	bought	Premium	Premium	Premium	-
2020-09-04	Premium	bought	Premium	Premium	Premium	-
2020-09-03	Premium	bought	Premium	Premium	Premium	-
2020-09-03	Premium	bought	Premium	Premium	Premium	-
2020-09-02	Premium	bought	Premium	Premium	Premium	-
2020-09-02	Premium	bought	Premium	Premium	Premium	-
2020-09-01	Premium	bought	Premium	Premium	Premium	-
2020-09-01	Premium	bought	Premium	Premium	Premium	-
2020-08-31	Premium	bought	Premium	Premium	Premium	-

TENX - Tenax Therapeutics Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for TENX